Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Am J Cardiol. 2020 Sep 15;136:24–31. doi: 10.1016/j.amjcard.2020.09.014

Table 2.

Outcomes of study cohort

Variable Cardiogenic Shock p Value
No (n = 245,441) Yes (n = 14,703)
Died 9,004 (4%) 3,363 (23%) p<0.01
Home 144,456 (59%) 4,186 (29%)
Short term Rehab 6,300 (3%) 743 (5%)
Skilled nursing facility 47,543(19%) 4,195 (29%)
Home with home health 36,538 (15%) 2,137 (14%)
Against medical advice 1,448 (0.6%) 69 (0.5%)
Resource utilization and procedures
Median (IQR) cost $ 39,560 (23,371–72,442) 116,860 (63,732–219,886) p<0.01
Median (IQR) length of stay, days 4 (2–7) 9(5–15) p<0.01
Ventilator use 33,048 (14%) 9,577 (65%) p<0.01
PEG 3,891 (2%) 707 (5%) p<0.01
Tracheostomy 1,966 (1%) 604 (4%) p<0.01
IABP - 3,167 (22%) p<0.01
pVADS - 411 (3%) p<0.01
Vasopressors - 1,842 (13%) p<0.01

Abbreviations: IABP = Intra-aortic balloon pump; PEG = Percutaneous gastrostomy tube; pVADS = Percutaneous ventricular assist devices.